Bullish options flow in $ABVX
$10.6M of Jan 21 2028 $125 puts traded at the bid. 2,325 contracts against 2,393 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Read the social chatter around a ticker before the move.
$10.6M of Jan 21 2028 $125 puts traded at the bid. 2,325 contracts against 2,393 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Read the social chatter around a ticker before the move.
November 4, 2026 at 3:30 PM
Bullish options flow in $ABVX
$10.6M of Jan 21 2028 $125 puts traded at the bid. 2,325 contracts against 2,393 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Read the social chatter around a ticker before the move.
$10.6M of Jan 21 2028 $125 puts traded at the bid. 2,325 contracts against 2,393 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Read the social chatter around a ticker before the move.
『秦 基博を歌う -Hata Motohiro Tribute-』全曲トレーラー
YouTube video by 秦 基博
youtube.com
November 4, 2026 at 1:37 PM
#$ABVX weekly close $86.59 (-1.6% w/w), below SMA50 $100.14 / below SMA200 $114.10, RSI 40.0. Support $84.11, resistance $96.39. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/abivax-abvx-...
New hub updated: www.merlintrader.com/abivax-abvx-...
October 31, 2026 at 9:06 AM
#$ABVX weekly close $86.59 (-1.6% w/w), below SMA50 $100.14 / below SMA200 $114.10, RSI 40.0. Support $84.11, resistance $96.39. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/abivax-abvx-...
New hub updated: www.merlintrader.com/abivax-abvx-...
#$ABVX weekly close $86.59 (-1.6% w/w), below SMA50 $100.14 / below SMA200 $114.10, RSI 40.0. Support $84.11, resistance $96.39. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/abivax-abvx-...
New hub updated: www.merlintrader.com/abivax-abvx-...
October 31, 2026 at 9:06 AM
#$ABVX weekly close $86.59 (-1.6% w/w), below SMA50 $100.14 / below SMA200 $114.10, RSI 40.0. Support $84.11, resistance $96.39. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/abivax-abvx-...
New hub updated: www.merlintrader.com/abivax-abvx-...
秦基博のトリビュートアルバム良いな〜。 www.youtube.com/watch?v=ABvX...
『秦 基博を歌う -Hata Motohiro Tribute-』全曲トレーラー
秦 基博 初のトリビュート・アルバム
＜リリース情報＞
■V.A.『秦 基博を歌う -Hata Motohiro Tribute-』
11月4日(水)Release
通常盤(1形態) UMCA-10164 3,200円(税抜)…
www.youtube.com
November 2, 2026 at 3:57 AM
秦基博のトリビュートアルバム良いな〜。 www.youtube.com/watch?v=ABvX...
$ABVX finished Monday at $86.50, below both the 50-day SMA ($102.65) and the 200-day ($116.14), near the bottom of its 20-day range ($84.11-$100.08). Daily RSI 38.
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#ABVX
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#ABVX
October 27, 2026 at 6:59 AM
$ABVX finished Monday at $86.50, below both the 50-day SMA ($102.65) and the 200-day ($116.14), near the bottom of its 20-day range ($84.11-$100.08). Daily RSI 38.
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#ABVX
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#ABVX
$ABVX — The Goldman Sachs Group, Inc. crossed 5.3% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
October 20, 2026 at 8:00 PM
$ABVX — The Goldman Sachs Group, Inc. crossed 5.3% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
📅 CATALYST REMINDER | #$ABVX
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
October 17, 2026 at 7:03 PM
📅 CATALYST REMINDER | #$ABVX
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
October 17–20, 2026 — Clinical Data | UEG Week
Abivax presents 7 obefazimod abstracts incl. Phase 3 ABTECT maintenance data. Next: FDA NDA filing targeted Q4 2026.
🔗 Full details: www.merlintrader.com/abivax-abvx-...
#ABVX #Biotech #UEGWeek2026
$ABVX — The Goldman Sachs Group, Inc. crossed 5.3% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
October 16, 2026 at 7:30 PM
$ABVX — The Goldman Sachs Group, Inc. crossed 5.3% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1795
#insiderbuying #europeanstocks #investing
Bearish options flow in $ABVX
$3.7M of Oct 16 $115 puts traded at the ask. 1,314 contracts against 1,481 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Build and train your own AI trading models right on your phone. No code required.
$3.7M of Oct 16 $115 puts traded at the ask. 1,314 contracts against 1,481 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Build and train your own AI trading models right on your phone. No code required.
October 14, 2026 at 7:00 PM
Bearish options flow in $ABVX
$3.7M of Oct 16 $115 puts traded at the ask. 1,314 contracts against 1,481 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Build and train your own AI trading models right on your phone. No code required.
$3.7M of Oct 16 $115 puts traded at the ask. 1,314 contracts against 1,481 open interest.
Every unusual $ABVX print, live:
https://fundspec.ai/s/ABVX/options
Build and train your own AI trading models right on your phone. No code required.
$ABVX — 5 institutions all took stakes in ABIVAX this week.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
October 12, 2026 at 9:00 PM
$ABVX — 5 institutions all took stakes in ABIVAX this week.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
$ABVX — Helikon Investments Limited crossed 5.0% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
October 12, 2026 at 8:30 PM
$ABVX — Helikon Investments Limited crossed 5.0% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
$ABVX — ABIVAX et détenir, indirectement, 4 501 768 actions ABIVAX représentant autant de…
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1755
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1755
#insiderbuying #europeanstocks #investing
October 12, 2026 at 8:00 PM
$ABVX — ABIVAX et détenir, indirectement, 4 501 768 actions ABIVAX représentant autant de…
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1755
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1755
#insiderbuying #europeanstocks #investing
$ABVX — 5 institutions all took stakes in ABIVAX this week.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
October 8, 2026 at 8:30 PM
$ABVX — 5 institutions all took stakes in ABIVAX this week.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale_cluster%3Aabivax
#insiderbuying #europeanstocks #investing
$ABVX — Helikon Investments Limited crossed 5.0% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
October 8, 2026 at 8:00 PM
$ABVX — Helikon Investments Limited crossed 5.0% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1725
#insiderbuying #europeanstocks #investing
$ABVX — ABIVAX et détenir, indirectement, 4 442 949 actions ABIVAX représentant autant de…
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1677
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1677
#insiderbuying #europeanstocks #investing
October 2, 2026 at 7:00 PM
$ABVX — ABIVAX et détenir, indirectement, 4 442 949 actions ABIVAX représentant autant de…
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1677
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1677
#insiderbuying #europeanstocks #investing
$ABVX — The Goldman Sachs Group, Inc crossed 5.5% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1678
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1678
#insiderbuying #europeanstocks #investing
October 2, 2026 at 5:01 PM
$ABVX — The Goldman Sachs Group, Inc crossed 5.5% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1678
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1678
#insiderbuying #europeanstocks #investing
$ABVX — BlackRock, Inc. crossed 5.1% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1638
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1638
#insiderbuying #europeanstocks #investing
September 28, 2026 at 8:30 PM
$ABVX — BlackRock, Inc. crossed 5.1% of ABIVAX.
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1638
#insiderbuying #europeanstocks #investing
https://www.insidereu.com/whales?issuer=ABIVAX&utm_source=bluesky&utm_medium=organic-social&utm_campaign=drip&utm_content=whale%3Afr-amf-226c1638
#insiderbuying #europeanstocks #investing
Sept 28, 2026: options flow shows bullish $NUAI and $ABVX. $NUAI: six straight sessions, $318K gross, $103K net, 4 contracts, 4 expiries. $ABVX: eight straight, $3.0M gross, $1.2M net, 20 contracts, 11 expiries.
September 28, 2026 at 12:51 PM
Sept 28, 2026: options flow shows bullish $NUAI and $ABVX. $NUAI: six straight sessions, $318K gross, $103K net, 4 contracts, 4 expiries. $ABVX: eight straight, $3.0M gross, $1.2M net, 20 contracts, 11 expiries.
#$ABVX Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue valuation, binary FDA risk, and heavy dilution leave little margin for execution error.
intickers.com/reports/abvx/
intickers.com/reports/abvx/
ABIVAX Société Anonyme (ABVX) Stock Analysis | InTickers
Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue…
intickers.com
September 27, 2026 at 10:30 PM
#$ABVX Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue valuation, binary FDA risk, and heavy dilution leave little margin for execution error.
intickers.com/reports/abvx/
intickers.com/reports/abvx/
Goldman Sachs Initiates Abivax Coverage With Buy Rating and $155 Target
Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) wi…
Read more: https://embers.news/article/goldman-sachs-initiates-abivax-coverage-with-buy-rating-and-155-target-73639
Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) wi…
Read more: https://embers.news/article/goldman-sachs-initiates-abivax-coverage-with-buy-rating-and-155-target-73639
Goldman Sachs Initiates Abivax Coverage With Buy Rating and $155 Target
Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) with a buy rating and a $155 price target. This initiation reflects analyst expectations for the commercial potential of the company's lead drug candidate, obefazimod, which is currently in devel
embers.news
September 25, 2026 at 2:50 PM
Goldman Sachs Initiates Abivax Coverage With Buy Rating and $155 Target
Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) wi…
Read more: https://embers.news/article/goldman-sachs-initiates-abivax-coverage-with-buy-rating-and-155-target-73639
Goldman Sachs has initiated research coverage on clinical-stage biotechnology firm Abivax (NASDAQ: ABVX) wi…
Read more: https://embers.news/article/goldman-sachs-initiates-abivax-coverage-with-buy-rating-and-155-target-73639
🎯 #$ABVX EARNINGS REACTION
3 analysts updated ABVX (Abivax) after earnings. Not one changed their rating.
Two firms cut: Truist Securities to $151 from $155 at Buy, and Wedbush to $118 from $140 at Neutral.
One kept its target unchanged.
3 analysts updated ABVX (Abivax) after earnings. Not one changed their rating.
Two firms cut: Truist Securities to $151 from $155 at Buy, and Wedbush to $118 from $140 at Neutral.
One kept its target unchanged.
September 22, 2026 at 3:55 PM
🎯 #$ABVX EARNINGS REACTION
3 analysts updated ABVX (Abivax) after earnings. Not one changed their rating.
Two firms cut: Truist Securities to $151 from $155 at Buy, and Wedbush to $118 from $140 at Neutral.
One kept its target unchanged.
3 analysts updated ABVX (Abivax) after earnings. Not one changed their rating.
Two firms cut: Truist Securities to $151 from $155 at Buy, and Wedbush to $118 from $140 at Neutral.
One kept its target unchanged.
Empresas que presentan balances el lunes 21/9 tras el cierre y el martes 22/9 antes de la apertura: $ABVX, $THO, $MLKN y $AZO.
September 22, 2026 at 2:50 AM
Empresas que presentan balances el lunes 21/9 tras el cierre y el martes 22/9 antes de la apertura: $ABVX, $THO, $MLKN y $AZO.